Neoadjuvant chemotherapy in patients with vulvar carcinoma: a systematic review
, 1, 1, 1, 1
Abstract
Neoadjuvant chemotherapy is one of the options of treating patients with vulvar carcinoma. In this systematic review we searched three databases (Medline, EMBASE, Cochrane Library) for literature regarding this method of therapy. Additional sources were also searched. We included primary studies of any design with no language or date restrictions. Fourteen full-text studies were found; due to heterogeneity of data no quantitative synthesis was performed. Quality of evidence was very low, mainly due to population sizes and no available comparative data with other types of treatment. The results were mixed, however some of the studies reported promising results regarding survival and possibility of more conservative surgery. In general chemotherapy was well-tolerated, but in some studies regimens containing bleomycin and methotrexate presented particularly severe toxicity.
Keywords: vulvar neoplasmsdrug therapy
References
- Banas T, Pitynski K, Jach R, et al. Primary Vulvo-Vaginal Cancers: Trends in Incidence and Mortality in Poland (1999-2012). Gynecol Obstet Invest. 2015; 80(4): 240–245.
- Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30 Suppl 5: F12–F23.
- Khanna N, Rauh LA, Lachiewicz MP, et al. Margins for cervical and vulvar cancer. J Surg Oncol. 2016; 113(3): 304–309.
- Case Studies in Appraisal. Positive Teacher Appraisal Through Classroom Observation. 2014: 57–95.
- Aragona AM, Cuneo N, Soderini AH, et al. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study. Int J Gynecol Cancer. 2012; 22(7): 1258–1263.
- Adorni M, Bazzurini L, Lissoni AA, et al. Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience. Tumori. 2022; 108(5): 495–501.
- Retrospective cohort study of neoadjuvant chemotherapy followed by tailored surgery in locally advanced sphincter-threatening vulval cancer: an alternative to exenteration? European Journal of Gynaecological Oncology. 2021; 42(5): 917.
- Raspagliesi F, Zanaboni F, Martinelli F, et al. Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva. J Gynecol Oncol. 2014; 25(1): 22–29.
- Perrone AM, Galuppi A, Borghese G, et al. Electrochemotherapy pre-treatment in primary squamous vulvar cancer. Our preliminary experience. J Surg Oncol. 2018; 117(8): 1813–1817.
- Niu Y, Yin R, Wang D, et al. Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article. Medicine (Baltimore). 2018; 97(34): e11786.
- Trattamento del carcinoma della vulva recidivo o localmente avanzato: ruolo e possibilita’ di chemioterapia neoadiuvante. universita’ degli studi di milano-bicocca dottorato di ricerca in ginecologia oncologica XXIII CICLO. https://boa.unimib.it/retrieve/e39773b1-7ceb-35a3-e053-3a05fe0aac26/Phd_unimib_534465.pdf.
- Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006; 100(1): 53–57.
- Benedetti-Panici P, Greggi S, Scambia G, et al. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol. 1993; 50(1): 49–53.
- Wagenaar HC, Colombo N, Vergote I, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol. 2001; 81(3): 348–354.
- Domingues AP, Mota F, Durão M, et al. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010; 20(2): 294–298.
- Bafna UD, Devi UMA, Naik KA, et al. Carcinoma of the vulva: a retrospective review of 37 cases at a regional cancer centre in South India. J Obstet Gynaecol. 2004; 24(4): 403–407.
- Durrant KR, Mangioni C, Lacave AJ, et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol. 1990; 37(3): 359–362.
- Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006; 95 Suppl 1: S7–27.
